Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Efficacy and safety of semaglutide versus placebo as add-on to insulin treatment in subjects with type 2 diabetes (SUSTAIN 5)
Mathieu C, Zinman B, Hemmingsson JU et al (2016) Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial
Diabetic retinopathy is a prognostic factor for progression of chronic kidney disease in the patients with type 2 diabetes mellitus
Scientific References Polycystic ovary syndrome (PCOS prevalence 813%) The Lancet
US$ 25.30
US$ 27.60
US$ 20.40
US$ 24.99
US$ 27.88
US$ 21.31
